BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Micromet AG 

Am Klopferspitz 19

Martinsried  Planegg  82152  Germany
Phone: 49-0-89-895277-0 Fax: +49-0-89-895277-22


SEARCH JOBS


Industry
Pharmaceutical

Segment
Drug Delivery

Collaborations

MedImmune 





 Company News
Amgen (AMGN) Completes Tender Offer for Outstanding Shares of Micromet 3/7/2012 10:04:51 AM    More...
Amgen (AMGN) Announces Initial Results of Tender Offer for Outstanding Shares of Micromet and Commencement of Subsequent Offering Period 3/5/2012 9:59:10 AM    More...
Buyout Offer for Micromet Triggers Shareholder-Claim Investigation by Goldfarb LLP Securities Attorneys 2/6/2012 9:30:56 AM    More...
Micromet Signs CRADA with National Cancer Institute to Expand Development of Blinatumomab 1/9/2012 6:35:48 AM    More...
Micromet’s Blinatumomab Produces Durable Responses in Patients with Relapsed Diffuse Large B Cell Lymphoma Patients 12/12/2011 7:49:18 AM    More...
Micromet Appoints Joseph Lobacki Senior Vice President and Chief Commercial Officer 12/5/2011 6:23:09 AM    More...
Micromet Initiates Global Phase 2 Trial of Blinatumomab in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia 11/28/2011 10:25:44 AM    More...
Micromet to Present at the 2011 Piper Jaffray Health Care Conference 11/23/2011 10:11:26 AM    More...
Micromet Reports Third Quarter 2011 Financial Results 11/8/2011 7:18:33 AM    More...
Micromet to Report Blinatumomab Data at 2011 American Society of Hematology Annual Meeting 11/8/2011 7:12:52 AM    More...
12345678910...

//-->